ECDC-EMCDDA review: Can active case finding help reduce communicable diseases in prisons?
ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have systematically retrieved and assessed evidence on active case findings for blood-borne viruses like HIV, hepatitis B and C, sexually transmitted infections as well as tuberculosis in prison settings in the EU/EEA.
E-learning course on how to increase influenza vaccination uptake
It is important that healthcare workers (HCWs) get vaccinated against seasonal influenza since they can get influenza from, and transmit influenza to, patients and other HCWs. This e-learning course has been developed since seasonal influenza vaccination of HCWs is recommended in Europe but vaccination uptake remains low in most countries. It provides information about how to assess the uptake and barriers to vaccination, as well as examples of successful campaigns that have increased the vaccination among HCWs. The target audience is public health professionals who organize vaccination campaigns for HCWs.
Influenza surveillance for the 2017-2018 season is starting
ECDC monitors and reports on influenza transmission and virus circulation in Europe on a weekly basis throughout the flu season, in collaboration with WHO Regional Office for Europe, in the report Flu News Europe.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
ERS Training Course: Acute respiratory pandemics: how to plan and manage
This practical course will cover outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and will focus around two practical scenarios in which participants will gain experience in managing an acute epidemic.
Sixth ESWI Influenza Conference
The ESWI Influenza Conferences are the largest European scientific conferences entirely dedicated to influenza. The 2017 conference runs 10 -13 September.
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
Epidemiological update: Review of influenza season 2016–2017 in the EU/EEA
The influenza season 2016–2017 has now come to an end in Europe. In week 17/2017, all EU/EEA countries reported low influenza activity and the positivity rate (proportion of influenza virus positives among all tested specimens) falling below the 10% benchmark to 9.9%. For the previous six weeks, almost all EU/EEA countries had reported low influenza activity.
Multidrug-resistant tuberculosis in migrants, multi-country cluster – ECDC risk assessment
ECDC has published a third update to assess the risk of transmission within the EU of a multidrug-resistant tuberculosis (MDR TB) strain initially detected by Switzerland in seven asylum seekers from the Horn of Africa. Recommendations are given to help improve the understanding and the public health impact of this cluster for the EU.